Loading company…
Novazyme Pharmaceuticals develops biotherapeutic products for the treatment of lysosomal storage disorders from Princeton, US.
Based in Princeton, US, Novazyme Pharmaceuticals develops biotherapeutic products for lysosomal storage disorders. The company is listed at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in